How to Buy Cohen & Steers Stock
Cohen & Steers Inc
Cohen & Steers is a asset management company located in New York, United States, which is part of the Financial Services sector, and is traded under the ticker CNS on the NYSE exchange.
Cohen & Steers stock last closed at $78.92, up 0.01% from the previous day, and has increased 3.71% in one year. It has underperformed other stocks in the Asset Management industry by 0.03 percentage points. Cohen & Steers stock is currently +23.06% from its 52-week low of $64.13, and -28.69% from its 52-week high of $110.67.
There are currently 50.97M shares of CNS outstanding. The market value of CNS is $4.02B. In the past 24 hours, 537,071 CNS shares were traded.
How to Buy Cohen & Steers Stock
Not sure how to invest in Cohen & Steers stock? Here's how.
- Figure out where to buy Cohen & Steers stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Cohen & Steers stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Pick your method of payment and add your details.
- Evaluate Cohen & Steers stock: The Cohen & Steers ticker symbol is CNS. Is Cohen & Steers stock a good investment? Should you buy shares of CNS? How do CNS's underlying business fundamentals look? Do top analysts think Cohen & Steers is a good buy? Why has CNS's stock price moved recently? (Hint: Our stock market research website can help you decide if CNS is a good stock to buy).
- Place your CNS purchase: Decide if you will purchase CNS shares at the current market price or use a limit order to purchase CNS shares at a particular price.
- Keep tabs on your CNS investment: Create a watchlist to get live updates on your new investment in Cohen & Steers stock.
Step 1: Figure out where to buy Cohen & Steers stock
You will need an online brokerage account to access the NYSE market and buy CNS stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the right brokerage, you'll need to fill out some personal details so you can buy CNS stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open a new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've created your account on the best stock app, you can securely and quickly fund your account:
Watch the video below to see the process of transferring funds into your brokerage account.
Step 4: Evaluate Cohen & Steers stock
Once you have chosen the best place to buy Cohen & Steers stock, it's crucial to evaluate their stock prior to investing, so you actually understand the risk as well as the upside.
Cohen & Steers stock quick numbers
Cohen & Steers Overview
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on CNS's stock page.
Is CNS stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge CNS's fair value.
Using relative valuations metrics:
- CNS could be undervalued based on its P/E ratio of 26.31x, relative to Asset Management industry P/E ratio of 31.05x
- CNS could be overvalued based on its P/B ratio of 7.86x, relative to Asset Management industry P/B ratio of 2.75x
- CNS could be overvalued based on its PEG ratio of 35x
You can do more valuation research on CNS's stock here.
CNS Financial Health
Positive Health Checks:
- CNS's operating cash flow of $96.69M allows it to safely service it's debt of $141.12M.
- Total CNS debt is lower than 5 years ago, relative to shareholder equity.
- CNS profit margin has gone up from 26.4% to 29.2% in the past year.
- CNS earnings of $198.01M is not enough to cover its interest payments.
Negative Health Checks:
- CNS has a relatively high debt to equity ratio of 0.46.
Is Cohen & Steers stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 sell side analysts who give forecasts on CNS, the consensus analyst rating on CNS is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Cohen & Steers stock forecast page.
CNS Technicals
CNS Performance Metrics
Last year, CNS earnings were $151.27M. In the past 5 year, CNS's earnings have increased by 1.03% per year. This was slower than the Asset Management industry average of 5.76%.
Last year, CNS revenue was $517.42M. Over the past five year, CNS's revenue has increased by 4.72% per year. This was slower than the Asset Management industry average of 17.26%.
Dive into CNS's earnings and revenue performance here.
What are CNS executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at CNS have sold more shares than they have bought.
Brandon Brown, Executive Vice President of CNS, was the latest CNS insider to sell. They sold $44,415.00 worth of CNS stock on Jan 31, 2025.
Get more info about who owns CNS shares here.
Can I rely on CNS as an income stream?
Cohen & Steers pays a dividend of 3.03%, compared to the Asset Management industry's average dividend yield of 5.94%. If you owned $1,000 of CNS stock, you would have been paid $30.28 in the past year.
Cohen & Steers dividend payments have consistently grown over the past decade but have not remained stable.
Dig into more info about Cohen & Steers dividend yield and history here.
CNS Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your CNS purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you want more info about buying stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your CNS investment
Now that you own some CNS shares, you'll want to keep up with your new company.
Start a watchlist to keep tabs on your CNS stock.
CNS Feed
How to Buy Stock in Cohen & Steers
To summarize, here are the 6 steps to buy stock in Cohen & Steers:
- Figure out where to buy Cohen & Steers stock
- Create your brokerage account
- Put funds into your investment account
- Evaluate Cohen & Steers stock
- Place your CNS purchase
- Keep tabs on your CNS investment
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Cohen & Steers, create your watchlist below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.